89898-86-2

Basic information

• Product Name: 5-NITROPHTHALAZINE
• Synonyms: 5-NITROPHTHALAZINE
• CAS NO: 89898-86-2
• Molecular Formula: C₈H₅N₃O₂
• Molecular Weight: 175.14
• Mol File: 89898-86-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 421.525 °C at 760 mmHg
• Flash Point: 208.731 °C
• Appearance: /
• Density: 1.437g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.695
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-NITROPHTHALAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-NITROPHTHALAZINE(89898-86-2)
• EPA Substance Registry System: 5-NITROPHTHALAZINE(89898-86-2)

Safety Data

• Hazardous Substances Data: 89898-86-2(Hazardous Substances Data)

Usage

Uses

5-nitrophthalazine is a useful chemical in the formation of a photothermographic material and used for image forming.

InChI:InChI=1/C8H5N3O2/c12-11(13)8-3-1-2-6-4-9-10-5-7(6)8/h1-5H

Upstream product

• 253-52-1 PHTHALAZINE 
• 484-23-1 1,4-bis(hydrazino)phthalazine 
• 91-15-6 phthalonitrile 

Downstream Products

• 102072-84-4 5-aminophthalazine 
• 102072-85-5 DA 3044 
• 502584-83-0 6-chloro-7-phenylamino-5,8-phthalazinedione 
• 147088-71-9 phthalazine-5,8-dione 

Relevant articles and documents

Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds

Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidation of aldehyde and aza-aromatic compounds and the hydrolysis of amides, moieties frequently shared by the majority of drugs. Despite its key role in human metabolism, to date only fragmentary information about the chemical features responsible for AOX susceptibility are reported and only "very local" structure-metabolism relationships based on a small number of similar compounds have been developed. This study reports a more comprehensive coverage of the chemical space of structures with a high risk of AOX phase I metabolism in humans. More than 270 compounds were studied to identify the site of metabolism and themetabolite(s). Both electronic [supported by density functional theory (DFT) calculations] and exposure effects were considered when rationalizing the structure-metabolism relationship.

Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma

Respiratory failure due to pulmonary metastasis is the major cause of death for patients with osteosarcoma. However, the molecular basis for metastasis of osteosarcoma is poorly understood. Recently, ezrin, a member of the ERM family of proteins, has been associated with osteosarcoma metastasis to the lungs. The small molecule NSC 668394 was identified to bind to ezrin, inhibit in vitro and in vivo cell migration, invasion, and metastatic colony survival. Reported herein are the design and synthesis of analogues of NSC 668394, and subsequent functional ezrin inhibition studies. The binding affinity was characterized by surface plasmon resonance technique. Cell migration and invasion activity was determined by electrical cell impedance methodology. Optimization of a series of heterocyclic-dione analogues led to the discovery of compounds 21k and 21m as potential novel antimetastatic agents.

4-Piperidinecarboxamide modulators of vanilloid VR1 receptor

This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.